PROGENICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM, CUSIP 743CVR037.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM, CUSIP 743CVR037.